Related Experiment Videos
Causes of refractoriness to platelet transfusion
1Department of Pathology, University of Alabama at Birmingham 35233-7331, USA.
Current Opinion in Hematology
|November 1, 1995
Summary
Platelet refractoriness, a complex issue in thrombocytopenic patients, requires identifying its causes for better transfusion practices. Understanding clinical, patient, and blood bank factors is key to improving patient outcomes.
Area of Science:
- Transfusion Medicine
- Hematology
- Clinical Pathology
Background:
- Platelet refractoriness presents a significant challenge in managing thrombocytopenic patients.
- Aggressive treatments are often employed, highlighting the need for improved management strategies.
Purpose of the Study:
- To identify the multifactorial causes of platelet refractoriness.
- To propose prevention and management strategies to enhance transfusion practices and patient outcomes.
Main Methods:
- Review of clinical studies evaluating causes of platelet refractoriness.
- Categorization of causes into clinically determined, patient-related, and blood bank-determined factors.
Main Results:
- Platelet refractoriness stems from diverse factors, including clinical, patient, and blood bank issues.
- Transfusion triggers and prophylactic transfusion practices warrant further investigation.
Conclusions:
- Identifying the source of refractoriness is crucial for effective prevention and management.
- Improvements in transfusion practices hold the greatest potential for mitigating platelet transfusion complications.